Regencell Bioscience Holdings annual net debt
2021
2022
2023
2024
2025
Regencell Bioscience Holdings Net Debt Growth & History (RGC)
Regencell Bioscience Holdings's net debt was −$1.9M for fiscal 2025.
View full Regencell Bioscience Holdings company overviewRegencell Bioscience Holdings annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | −$1.9M | $1.0M | — |
| 2024 | 2024-06-30 | −$2.9M | −$1.8M | — |
| 2023 | 2023-06-30 | −$1.1M | $4.5M | — |
| 2022 | 2022-06-30 | −$5.6M | −$8.8M | — |
| 2021 | 2021-06-30 | $3.2M | — | — |
Regencell Bioscience Holdings quarterly net debt
Q4.21
Q4.22
Q4.23
Q4.24
Q4.25
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-06-30 | −$1.9M | $1.0M | — |
| Q4 2024 | 2024-06-30 | −$2.9M | −$1.8M | — |
| Q4 2023 | 2023-06-30 | −$1.1M | $4.5M | — |
| Q4 2022 | 2022-06-30 | −$5.6M | −$8.8M | — |
| Q4 2021 | 2021-06-30 | $3.2M | — | — |
Regencell Bioscience Holdings net debt trends
Between the periods ended 2021-06-30 and 2025-06-30, Regencell Bioscience Holdings's net debt decreased from $3.2M to −$1.9M, a change of −$5.1M. The latest reported quarter, Q4 2025, shows −$1.9M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Regencell Bioscience Holdings source filings ↗